Sanofi India Ltd vs Sat Kartar Shopping Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Sanofi India Ltd is ₹ 3402 as of 05 May 15:30 . The P/E Ratio of Sanofi India Ltd is 30.8 as of December 2023 .The P/E Ratio of Sat Kartar Shopping Ltd is 0 as of December 2023 . The Market Cap of Sanofi India Ltd is ₹ 18578 crore as of December 2023 .The Market Cap of Sat Kartar Shopping Ltd is ₹ 0 crore as of December 2023 . The Revenue of Sanofi India Ltd is ₹ 578.9 crore as of Jun '24 .The Revenue of Sat Kartar Shopping Ltd is ₹ 0 crore as of Jun '24 . The EBITDA of Sanofi India Ltd is ₹ 178.5 crore as of Jun '24 .The EBITDA of Sat Kartar Shopping Ltd is ₹ 0 crore as of Jun '24 . The Net Profit of Sanofi India Ltd is ₹ 136.6 crore as of Jun '24 .The Net Profit of Sat Kartar Shopping Ltd is ₹ 0 crore as of Jun '24 . The dividend payout of Sanofi India Ltd changed from 119.34 % to 0 % over 9 quarters. This represents a CAGR of -100.00% The dividend payout of Sat Kartar Shopping Ltd changed from 3.11 % to 11.22 % over 2 quarters. This represents a CAGR of 1201.56% .

About Sanofi India Ltd

Sanofi India Limited, was initially incorporated as 'Aventis Pharma Limited' in May, 1956.
The Company changed its name from Aventis Pharma Limited to Sanofi India Limited on May 11, 2012.
The Company is amongst the leading multinational companies (MNCs) in the Indian Pharmaceutical Market.
The Company is primarily engaged in the business of manufacturing and trading of drugs s and pharmaceuticals.
It has its own manufacturing facility at Goa.

About Sat Kartar Shopping Ltd

Sat Kartar Shopping Limited was incorporated as a Private Limited Company with the name of 'Sat Kartar Shopping Private Limited' vide Certificate of Incorporation dated June 29, 2012, issued by Registrar of Companies, Delhi.
Further, Company converted into a Public Limited Company & name of the Company was changed to Sat Kartar Shopping Limited & Registrar of Companies, Delhi has issued a New Certificate of Incorporation consequent upon conversion dated July 12, 2021.
Manprit Singh Chadha is the Promoter of the Company. Sat Kartar Shopping is an Ayurveda healthcare company committed to providing natural wellness solutions relating to specific therapeutic areas and general lifestyle products, committed to promote a healthier lifestyle.
It integrate traditional Ayurvedic knowledge with modern research to empower individuals to adopt healthier lifestyles.

FAQs for the comparison of Sanofi India Ltd and Sat Kartar Shopping Ltd

Which company has a larger market capitalization, Sanofi India Ltd or Sat Kartar Shopping Ltd?

Market cap of Sanofi India Ltd is 8,111 Cr while Market cap of Sat Kartar Shopping Ltd is 316 Cr

What are the key factors driving the stock performance of Sanofi India Ltd and Sat Kartar Shopping Ltd?

The stock performance of Sanofi India Ltd and Sat Kartar Shopping Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sanofi India Ltd and Sat Kartar Shopping Ltd?

As of May 5, 2026, the Sanofi India Ltd stock price is INR ₹3522.25. On the other hand, Sat Kartar Shopping Ltd stock price is INR ₹201.2.

How do dividend payouts of Sanofi India Ltd and Sat Kartar Shopping Ltd compare?

To compare the dividend payouts of Sanofi India Ltd and Sat Kartar Shopping Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.